CLINICAL TRIALS PROFILE FOR DEUCRAVACITINIB
✉ Email this page to a colleague
All Clinical Trials for Deucravacitinib
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03920267 ↗ | Long-Term Safety and Efficacy Study of Deucravacitinib in Participants With Systemic Lupus Erythematosus | Recruiting | Bristol-Myers Squibb | Phase 2 | 2019-03-26 | The main objective of the trial is to characterize the long-term safety and tolerability of BMS-986165 in subjects with Systemic Lupus Erythematosus (SLE). |
NCT03934216 ↗ | Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis | Active, not recruiting | Bristol-Myers Squibb | Phase 2 | 2019-07-01 | The purpose of this study is to assess the safety and efficacy of oral deucravacitinib in participants with moderate to severe ulcerative colitis (UC). |
NCT04036435 ↗ | Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis | Recruiting | Bristol-Myers Squibb | Phase 3 | 2019-08-12 | The main purpose of this study is to characterize the long-term safety and efficacy of the drug Deucravacitinib (BMS-986165) in patients who have been previously enrolled in an applicable Phase 3 psoriasis study. |
NCT04536961 ↗ | A Study to Evaluate the Drug Levels of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants | Completed | Bristol-Myers Squibb | Phase 1 | 2020-09-10 | The purpose of this study is to evaluate the drug levels of BMS-986165 in when taken by mouth as various solid tablet prototypes, by healthy participants. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Deucravacitinib
Condition Name
Clinical Trial Locations for Deucravacitinib
Trials by Country
Clinical Trial Progress for Deucravacitinib
Clinical Trial Phase
Clinical Trial Sponsors for Deucravacitinib
Sponsor Name